IVY THOMPSON: Open Payments
NPI 1164079828 · MILFORD, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 17 payments from 8 companies in 2025. Trend: 2023 $26 · 2024 $1,293 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $87 |
| Novo Nordisk Inc | 4 | $78 |
| Corcept Therapeutics | 2 | $53 |
| ABBVIE INC. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Exact Sciences Corporation | 1 | $30 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $16 |
Products named: Korlym, FARXIGA, VRAYLAR, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, AIRSUPRA, NEXLETOL, BREZTRI.
Industry payments across DE — which companies pay providers there.
